Equillium (EQ) Total Current Liabilities (2017 - 2026)
Equillium (EQ) posted quarterly Total Current Liabilities of $3.3 million for Q1 2026, down 44.27% year-over-year from $6.0 million in Q1 2025, and up 14.01% quarter-over-quarter from $2.9 million in Q4 2025.
Equillium (EQ) Total Current Liabilities (2017 - 2026) Analysis & Trends
Equillium (EQ) has reported Total Current Liabilities for 10 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 44.27% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 44.27% YoY), while the FY2025 annual figure was $2.9 million, down 53.84% from the prior year.
- Total Current Liabilities grew to $3.3 million in Q1 2026 per EQ's latest filing, from $2.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $32.0 million in Q4 2022 and bottomed at $2.9 million in Q4 2025.
- Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $14.9 million in 2022.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 259.37% — and 2024, when it slumped 76.95%.
- Equillium's Total Current Liabilities stood at $32.0 million in 2022, then declined by 13.94% to $27.6 million in 2023, then plunged by 76.95% to $6.4 million in 2024, then plunged by 53.84% to $2.9 million in 2025, then increased by 14.01% to $3.3 million in 2026.
- Business Quant data shows EQ's Total Current Liabilities at $3.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Mn |
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 7.23 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 11.06 Mn |
| Jun 30, 2024 | 20.17 Mn |
| Mar 31, 2024 | 22.21 Mn |
| Dec 31, 2023 | 27.57 Mn |
| Sep 30, 2023 | 28.20 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 32.02 Mn |
| Dec 31, 2022 | 32.04 Mn |
| Sep 30, 2022 | 14.93 Mn |
| Jun 30, 2022 | 15.19 Mn |
| Mar 31, 2022 | 13.11 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 7.78 Mn |